Development of XEN2174 and an escalating safety and tolerability study of intrathecal use in oncology patients

Brust, A., Colless, B., Cousins, M., Day, D., Drinkwater, R., Gouke, R., Hughes, D., Lewis, R. J., Martin, W., Nielson, C., Palant, E., Rauck, R., Schmidt, P., Smith, M. T. and Steams, L. J. (2009). Development of XEN2174 and an escalating safety and tolerability study of intrathecal use in oncology patients. In: Proceedings of the twenty-first American peptide symposium. Michal Lebl Peptides Breaking Away, Bloomington, Indiana, U.S.A., (301-301). 7-12 June, 2009.

Author Brust, A.
Colless, B.
Cousins, M.
Day, D.
Drinkwater, R.
Gouke, R.
Hughes, D.
Lewis, R. J.
Martin, W.
Nielson, C.
Palant, E.
Rauck, R.
Schmidt, P.
Smith, M. T.
Steams, L. J.
Title of paper Development of XEN2174 and an escalating safety and tolerability study of intrathecal use in oncology patients
Conference name Michal Lebl Peptides Breaking Away
Conference location Bloomington, Indiana, U.S.A.
Conference dates 7-12 June, 2009
Proceedings title Proceedings of the twenty-first American peptide symposium   Check publisher's open access policy
Journal name Biopolymers   Check publisher's open access policy
Place of Publication San Diego, C.A. U.S.A.
Publisher American Peptide Society
Publication Year 2009
Sub-type Fully published paper
ISBN 0-9715560-3-2
ISSN 0006-3525
Volume 92
Issue 4
Start page 301
End page 301
Total pages 1
Language eng
Subjects EX
111501 Basic Pharmacology
111502 Clinical Pharmacology and Therapeutics
920111 Nervous System and Disorders
Q-Index Code EX
Q-Index Status Provisional Code

Document type: Conference Paper
Collections: ResearcherID Downloads
School of Pharmacy Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Tue, 12 Jan 2010, 19:34:44 EST by Charna Kovacevic on behalf of School of Pharmacy